Knee joint replacement. Unspecified complication of internal orthopedic prosthetic device, implant and graft
Conditions
Interventions
Intervention 1: Intervention group1: After surgery, through an infusion pump (syringe pump), dexmedetomidine (Elixir Pharmaceutical Company) 1 microgram per kg and dexamethasone (Caspian Tamin Pharmac
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 18 to 85 years old Body mass index of 38 kg m2 or less Candidate for knee joint replacement surgery Absence of underlying disease Absence of sensitivity to any of the studied drugs Absence of neuropathy in the operated organ No history of chronic pain Absence of spinal contraindications
Exclusion criteria
Exclusion criteria: Lack of cooperation Lack of consent to participate in the study For any reason, spinal anesthesia becomes ineffective in the patient and another anesthesia method is used to continue the operation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Recovery and 2-4-8-12-24 hours after the operation. Method of measurement: Visual analog scale of pain.;Mean drug consumption in 24 hours after surgery. Timepoint: At the end of the study. Method of measurement: Physical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Hesamedin Modir
Arak University of Medical Sciences
Outcome results
None listed